Understand the Continued Dominance of Coversyl within Servier's Portfolio, and How this will Slow the Company's Growth Prospects to 2010.DUBLIN Dublin, city, Republic of Ireland Dublin, Irish Baile Átha Cliath, county borough (1991 pop. 915,516), Leinster, capital of the Republic of Ireland, on Dublin Bay at the mouth of the Liffey River. , Ireland Ireland, Irish Eire (âr`ə) [to it are related the poetic Erin and perhaps the Latin Hibernia], island, 32,598 sq mi (84,429 sq km), second largest of the British Isles. -- Research and Markets (http://www.researchandmarkets.com/reports/c30866) has announced the addition of Servier Servier Laboratories is a privately owned French pharmaceutical company that specialises in medication for cardiological and rheumatological conditions, as well as for diabetes and depression.[1] The consolidated turnover for the 2005/2006 financial year was €3. : Pharmavitae Profile 2005 to their offering. This Company Analysis examines the current position and future outlook for Servier in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts Sales forecast A key input to a firm's financial planning process. External sales forecasts are based on historical experience, statistical analysis, and consideration of various macroeconomic factors. for key drugs. An interactive forecasting and analysis tool provides updated quantitative and qualitative qualitative /qual·i·ta·tive/ (kwahl´i-ta?tiv) pertaining to quality. Cf. quantitative. qualitative pertaining to observations of a categorical nature, e.g. breed, sex. information. Reasons to Purchase -- Benchmark Servier's performance against key rivals in the ethical pharmaceutical sector -- Learn how organic growth is set to continue with the recently launched Osseor and late stage pipeline products all discovered and developed internally -- Understand the continued dominance of Coversyl within Servier's portfolio, and how this will slow the company's growth prospects to 2010 The following key topics are explored in this report: -- Key findings -- Current positioning: competitive outlook 2004 -- Servier's forecast revenue stream, 2005-10 -- Strategic outlook -- Strategic recommendations -- Key issues facing Servier: 2004 - 10 For more information visit http://www.researchandmarkets.com/reports/c30866 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion